View All Immuno-Oncology Resources

To learn more about a unique approach to combining oncology and subspecialist expertise toward the goal of effective irAE management, the ACCC Institute for Clinical Immuno-Oncology spoke with medical oncologist Ryan Weight, DO, MS from the Sidney Kimmel Cancer Center (SKCC) of the Thomas Jefferson University, Philadelphia, Pennsylvania.

Experts from the Saint Agnes Cancer Institute in Baltimore, Maryland hosted an Institute for Clinical Immuno-Oncology (ICLIO) Visiting Experts workshop to accelerate their learning about managing patients being treated with immuno-oncology (I-O) agents.

Learn how the microbiome could potentially be used to predict and enhance response to I-O therapy and to recognize patients who could be at risk for developing immune-related adverse events.

Mounting evidence suggests that the gut microbiome (or microbiota) plays a fundamental role in the activation, regulation, and function of the immune system. There is ongoing interest in the relationship between the gut microbiome and cancer development.